Friday, November 28, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Insider Exodus Casts Shadow Over NuScale Power’s Nuclear Ambitions

Dieter Jaworski by Dieter Jaworski
October 13, 2025
in Analysis, Insider Trading, Renewable Energy, Trading & Momentum
0
Nuscale Power Stock
0
SHARES
13
VIEWS
Share on FacebookShare on Twitter

NuScale Power shares are navigating turbulent trading conditions characterized by extreme price swings and concerning insider liquidation patterns. Despite the company’s celebrated technological advancements, transaction data reveals a troubling disconnect between corporate achievements and executive confidence.

Significant Insider Liquidations Raise Concerns

Corporate insiders have executed substantial share disposals over the recent quarter, creating headwinds for investor sentiment. The most dramatic transaction occurred on September 19th, when a company director divested 2.37 million shares at an average price of $43.99, generating proceeds of approximately $104.37 million.

Equally noteworthy was Fluor Corporation’s complete exit from its position. On October 7th and 8th, the entity sold 909,551 shares across prices ranging from $39.42 to $43.13, realizing total proceeds of $36.87 million. This transaction eliminated Fluor’s direct holdings in the company entirely.

The cumulative picture over the past 90 days presents a stark narrative: insiders have transferred 15.05 million shares valued at $606.76 million, signaling substantial internal divestment from the nuclear technology firm.

Trading Volatility Reaches Extreme Levels

Friday’s session exemplified the stock’s turbulent nature, with shares declining 3.37% to close at $39.24. More alarming than the price drop was the trading range, which spanned 14.65% between the day’s peak and trough. As prices retreated, trading volume surged to 36 million shares—an increase of 14 million shares from previous levels—representing approximately $1.41 billion in transaction value.

Despite recent pressure, the equity shows mixed performance across different time horizons. The stock has gained 3.26% over two weeks and advanced 12.7% throughout the past three months. However, it has underperformed the broader technology sector, which returned 15.7% over the same quarterly period. The 52-week range between $11.08 and $53.50 underscores the security’s exceptional volatility.

Should investors sell immediately? Or is it worth buying Nuscale Power?

Nuclear Technology Developments Provide Counterbalance

Amid the selling pressure and price fluctuations, NuScale continues to achieve significant operational milestones:

  • Historic Power Project: The company is supporting development of up to 6 gigawatts of small modular reactor capacity across seven U.S. states, representing the largest SMR project in American history through its partnership with the Tennessee Valley Authority.

  • Regulatory Milestone: The Nuclear Regulatory Commission granted design approval for NuScale’s 77-megawatt reactor during the second quarter of 2025.

  • New Coverage Initiation: RBC Capital Markets commenced coverage with a “Sector Perform” rating and established a $35.00 price target, though classified the investment as “Speculative Risk.”

The fundamental question facing investors is whether NuScale’s technological progress can eventually translate into sustainable share price appreciation despite the overwhelming insider selling. The upcoming quarterly earnings call scheduled for October 7th may provide crucial insights. Until then, market participants must weigh promising nuclear technology developments against concerning internal transaction patterns in what remains highly volatile trading conditions.

Ad

Nuscale Power Stock: Buy or Sell?! New Nuscale Power Analysis from November 28 delivers the answer:

The latest Nuscale Power figures speak for themselves: Urgent action needed for Nuscale Power investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 28.

Nuscale Power: Buy or sell? Read more here...

Tags: Nuscale Power
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Oracle Stock
AI & Quantum Computing

Oracle’s High-Stakes AI Gamble Raises Alarm Bells

November 28, 2025
Eutelsat Stock
Analysis

Eutelsat Shares: JPMorgan Reverses Its Stance in Surprise Move

November 28, 2025
Rocket Lab USA Stock
Analysis

Rocket Lab Shares Surge as Institutional Investors Counter Insider Selling

November 28, 2025
Next Post
Boeing Stock

Boeing Faces Mounting Regulatory Scrutiny Amid Safety Incidents

Qualcomm Stock

Chipmaker Qualcomm Faces Dual Threat from Trade Wars and Regulatory Scrutiny

QuantumScape Stock

Solid-State Battery Pioneer QuantumScape Forges Critical Manufacturing Partnerships

Recommended

Silicon Motion Stock

The Unseen Engine: Silicon Motion Powers Next-Generation AI and Automotive Innovation

3 months ago
MicroStrategy Stock

MicroStrategy Shares Plunge as Bitcoin Strategy Backfires

2 months ago
Biotechnology Trading online

Jasper Therapeutics Presents Groundbreaking Preclinical Data on Briquilimabs Effectiveness in Preventing Allergic Reactions in Mice

2 years ago
Trinity Biotech Stock

Trinity Biotech Shares Face Persistent Downward Pressure

3 weeks ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Rocket Lab Shares Surge as Institutional Investors Counter Insider Selling

A Baffling Discount: Strategy’s Stock Defies Logic

Tesla Shares: Navigating a Crossroads of Innovation and Concern

Veradigm Shares Test Key $5 Resistance Level

Gold’s Unstoppable Ascent: Rally Defies Major Trading Halt

XRP’s Market Paradox: Technical Gloom Meets Institutional Accumulation

Trending

Lynas Stock
Asian Markets

Lynas Faces Dual Challenges as Production Halt Meets China Policy Shift

by Robert Sasse
November 28, 2025
0

Australia's premier rare earths producer, Lynas, finds itself navigating turbulent waters. Just as global markets seek alternatives...

Oracle Stock

Oracle’s High-Stakes AI Gamble Raises Alarm Bells

November 28, 2025
Eutelsat Stock

Eutelsat Shares: JPMorgan Reverses Its Stance in Surprise Move

November 28, 2025
Rocket Lab USA Stock

Rocket Lab Shares Surge as Institutional Investors Counter Insider Selling

November 28, 2025
Strategy Stock

A Baffling Discount: Strategy’s Stock Defies Logic

November 28, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Lynas Faces Dual Challenges as Production Halt Meets China Policy Shift
  • Oracle’s High-Stakes AI Gamble Raises Alarm Bells
  • Eutelsat Shares: JPMorgan Reverses Its Stance in Surprise Move

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com